Evaluation of Microglial Activation in ALS With [18F]PBR06 (Peripheral Benzodiazepine Receptor-06) PET
Completed · Phase 1
Conditions studied: Healthy Volunteers, Amyotrophic Lateral Sclerosis
In brief
The overall goal of this protocol is to evaluate microglial activation in the brain using \[18F\]PBR06 in patients with amyotrophic lateral sclerosis (ALS).
Key facts
- Study ID
- NCT03876002
- Run by
- Molecular NeuroImaging
- People needed
- 23
- Starts
- 2016-06-28
- Expected to finish
- 2018-02-07
- Last updated by the study team
- 2019-03-26
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
Where it is running
- Molecular NeuroImaging, LLC — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.